Gelatin

Subscribe to Selected New Research on Gelatin

1698 relevant articles (70 outcomes, 194 trials/studies) found for this Bio-Agent

Description: A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.

Also Known As:

Gelafusal; Gelatins

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Tabata, Yasuhiko: 18 articles (10/2007 - 04/2002)
2.	Sakaguchi, M: 7 articles (05/2002 - 03/2000)
3.	Inouye, S: 7 articles (05/2002 - 03/2000)
4.	Kushibiki, Toshihiro: 5 articles (03/2007 - 07/2004)
5.	Katsumori, Tetsuya: 4 articles (05/2007 - 01/2002)
6.	Nakayama, T: 4 articles (05/2002 - 09/2000)
7.	Kao, Weiyuan John: 3 articles (09/2007 - 05/2005)
8.	Komeda, Masashi: 3 articles (08/2007 - 06/2003)
9.	Tanaka, Etsuro: 3 articles (05/2007 - 03/2003)
10.	Mori, Hidezo: 3 articles (05/2007 - 03/2003)

Related Diseases

1.	Neoplasms (Cancer) 05/01/1996 - "The addition of gelatin sponge improved results only in tumors larger than 9 cm. Recurrence after an initial response was due more to the appearance of new daughter nodules in new locations rather than recrudescence of the presenting tumor." 12/01/2003 - "These findings suggest that tumor cell culture in vivo in a gelatin matrix is effective for early localization of tumor cells in vivo and that mesenchymal progenitor cells effectively inhibit the growth of the tumor cells in vivo." 05/01/2007 - "The results of this study show that PEG-modified gelatin-based nanovectors can serve as a safe and effective systemically administered gene delivery vehicle for solid tumor." 08/01/2009 - "Capitalizing on this effect, we demonstrate the efficacy of the molecular specific photoacoustic imaging technique using subcutaneous tumor-mimicking gelatin implants in ex-vivo mouse tissue. " 09/01/2009 - "The present study investigated whether or not the gelatin exerted anti-tumor effect in vivo. " Order ALL the reference details at left...
2.	Infection 10/01/1998 - "Gelatin coating alone may provide protection against infection. " 10/01/2005 - "Further studies should address the risks of gelatin sponge particles in the peripheral arteries of the uterine endometrium, as they may induce inflammatory processes and evoke complications including infection and menopause." 11/01/2004 - "METHOD OF STUDY: ASA were studied in sera from patients (142 with genital, 57 with ocular chlamydial infections) and control group (n = 100) by gelatin and tray agglutination test (TAT), sperm immobilization test (SIT) and ELISA. " 06/01/2009 - "Gelatin matrix was associated with a greater infection rate than MPH. " 06/01/2009 - "RESULTS: Application of gelatin matrix resulted in more cfu/g of tissue and an 87% infection rate, with fewer cfu/g of tissue and a 14% and 24% infection rate in the control and MPH groups, respectively. " Order ALL the reference details at left...
3.	Hemorrhage 09/01/1997 - "CONCLUSION: Selective embolization of the uterine vessels with gelatin sponge pledgets is a safe and effective method of managing pregnancy-related hemorrhage. " 09/01/2006 - "This study describes the use of a porcine model to test the ability of gelatin sponge injection into the tract to limit bleeding at the site of cryoprobe puncture. " 01/01/1955 - "[Experimental study of modified gelatin fluids in the treatment of massive hemorrhage (40 % of the total blood volume).]" 09/01/2009 - "TAE performed with gelatin sponge allowed to control the bleeding in all patients. " 09/01/2009 - "CONCLUSIONS: Although transcatheter arterial embolization with microcoils took a greater amount of time, transcatheter arterial embolization with NBCA or microcoils was more effective and feasible than that with gelatin sponge particle in terms of hemostasis and prevention of recurrent hemorrhage in a coagulopathic condition." Order ALL the reference details at left...
4.	Wounds and Injuries (Trauma) 01/01/2008 - "In this study, we report for the first time that the enzymatic hydrolysates from type-B porcine hide gelatin has potent neuroprotective activity against H(2)O(2)- or serum deprivation-induced injuries of cultured SH-SY5Y cells. " 09/01/2007 - "Employing human keratinocytes cultured on macroporous gelatin spheres to treat full thickness-wounds: an in vivo study on athymic rats." 03/01/2007 - "Pups were sacrificed at defined time points (2-72 h) after trauma and brains were processed for molecular studies (semiquantitative and real-time PCR, Western blot, gelatin zymography) and histology. " 07/01/2005 - "To investigate the question what happens to the tissue lost at the entrance wound, experimental studies were performed on composite models consisting of dyed pig skin and gelatin blocks. " 01/01/1999 - "Gelatin-derived bioadhesives for closing skin wounds: an in vivo study." Order ALL the reference details at left...
5.	Postoperative Pain 11/01/2008 - "PURPOSE: To prospectively evaluate and study the role, relative safety, and efficacy of using absorbable gelatin tissue hemosealant (Spongostan) in patients selected for a gelatin-assisted "tubeless" percutaneous nephrolithotomy (PCNL); to study whether it facilitates and further reduces the morbidity vis-à-vis tubeless PCNL without gelatin; and to compare postoperative pain, analgesia requirement, hospital stay, return to work time, and other parameters in patients undergoing tubeless PCNL with gelatin and tubeless PCNL without the gelatin sealant. " 01/01/1991 - "1. Two separate placebo-controlled studies of parallel design were carried out to evaluate the efficacy of single doses (400 mg) of soluble ibuprofen, ibuprofen liquid in a gelatin capsule and ibuprofen tablets (Nurofen), in patients with postoperative pain after third molar surgery. " 06/01/2003 - "Gelatin A microspheres (MS) of ketorolac tromethamine (KT) for intranasal systemic delivery were developed with the aim to avoid gastro-intestinal complications, to improve patient compliance, to use as an alternative therapy to conventional dosage forms, to achieve controlled blood level profiles, and to obtain improved therapeutic efficacy in the treatment of postoperative pain and migraine. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Thrombin
2.	Rifampin (Rifampicin)
3.	Collagen
4.	Hydrogel
5.	Polymers
6.	Polyethylene Terephthalates (Polyethylene Terephthalate)
7.	Ethylene Glycol (Monoethylene Glycol)
8.	Anti-Bacterial Agents (Antibiotics)
9.	Cisplatin (Platino)
10.	Fibrin Tissue Adhesive (Fibrin Sealant)

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Microspheres (Microsphere)
3.	Absorbable Gelatin Sponge
4.	Drug Therapy (Chemotherapy)
5.	Hepatectomy

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>